SOURCE: Axxess Pharma Inc.

Axxess Pharma Inc.

September 12, 2013 08:00 ET

Axxess Pharma Inc. President, Daniel Bagi, M.D. Provides Exclusive Interview on StockTradersTalk.com

TORONTO--(Marketwired - Sep 12, 2013) - Axxess Pharma Inc -- (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company -- is pleased to announce its President, Daniel Bagi, M.D. was featured as a guest in an exclusive interview on Wednesday September 11, 2013.

This interview discussed pending acquisitions, license deals, new additions to management, and plans for growth.

To listen to the full interview, please click on the following link: http://www.stocktraderstalk.com/

About StockTradersTalk:

StockTradersTalk specializes in radio interviews, and believes that when a CEO has the ability to demonstrate their passion, and personally cover talking points for their company it serves as the ultimate delivery platform. Press Releases have value, however, they lack the effectiveness of a webcast in helping a CEO connect with both current and potential shareholders on a personal level.

Stock Traders Talk Radio is an uncensored, comprehensive approach to disseminating vital facts about public companies trading on the OTC Markets.

About Axxess Pharma Inc.:

Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, -- to optimal health management through improved nutritional supplements.

Safe Harbor Statement:

Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

Contact Information